Somatic activating mutations of EZH2 have also been found in diffuse large B-cell lymphoma and follicular lymphoma, whereas inactivating mutations have been reported in myeloid neoplasms, suggesting context-dependent roles of EZH2 in tumorigenesis45,46. The gene discussed is EZH2; the disease is myeloid neoplasm.